PIVAC 2019

Topics (PIVAC):

  • Immunotherapeutic targets for the treatment of adult B-cell acute lymphocytic leukaemia
  • Ageing and the human immune system in the era of cancer immunotherapy
  • Epitope Spreading to Enhance the Effectiveness of TCR Transduced T Cells
  • The gap between the epitopes predicted, and those actually recognized by CD8 T cells
  • The exercise of TAMing the immune system
  • T cell suppression by cancer cells
  • The amino acid transporter xCT in breast cancer (stem) cells
  • T-cell monitoring for clinical studies: main techniques, pitfalls, and quality assurance
  • New generation of personalized cancer vaccines
  • The cross-talk between cancer and myeloid cells promotes tumor development by immune dependent and independent mechanisms
  • New strategies to reprogram dysfunctional tumor-infiltrating T cells in paediatric high-risk neuroblastoma
  • Assessment of Antibody Affinity Using ELISPOT/Fluorospot
  • Cancer Immune Escape: MHC expression in primary tumors “versus” metastatic lesions
  • NK cell immunosenescence and NK cell-based immunotherapy in AML patients
  • Ιn situ cancer vaccines: Tumor ablation and immune stimulation
  • Targeting aGARP on human Tregs: a novel approach for the immunotherapy of cancer?
  • Role of miRNAs and RNA-binding proteins for the immune escape of tumors
  • Adoptive T-cell therapy in academia – Oslo experiences
  • Survival of the fittest: How do myeloid-derived suppressor cells (MDSC) survive in the inhospitable tumor microenvironment?